InsiderTrades

Form 4 for TWST Twist Bioscience Corp

Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-14 · accession 0001214659-21-013286 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-16 2021-12-14 TWST Weiss Patrick COO S - Sale+OE $84.00 -2,801 47.5K -6% -$235.3K
DM 2021-12-16 2021-12-14 TWST Weiss Patrick COO M - OptEx $26.18 +2,801 49.5K +6% +$73.3K
DM 2021-12-16 2021-12-14 TWST Weiss Patrick COO M - OptEx $0.00 -2,801 19.9K -12% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-14 S D 2,801 $84.00 47,488 D — —
2 Common Common Stock 2021-12-14 M A 827 $25.02 50,289 D — —
3 Common Common Stock 2021-12-14 M A 1,974 $26.66 49,462 D — —
4 Derivative Employee Stock Option (right to buy) 2021-12-14 M D 1,974 $0.00 47,376 D $26.66 · — to 2028-11-18 1,974 Common Stock (F2) 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
5 Derivative Employee Stock Option (right to buy) 2021-12-14 M D 827 $0.00 19,859 D $25.02 · — to 2029-12-09 827 Common Stock (F3) 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.